Bedell Frazier Investment Counselling’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bedell Frazier Investment Counselling's GILD Position: Q3 2020 in Review
Bedell Frazier Investment Counselling sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 46,767 shares — an estimated $3.6M sold.
Bedell Frazier Investment Counselling first reported a position in GILD in Q3 2016 and held it in 16 quarters. The position peaked at $8.5M in Q3 2018. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Bedell Frazier Investment Counselling reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Bedell Frazier Investment Counselling sold 46,767 Gilead Sciences shares in Q3 2020, an estimated $3.6M.
- Bedell Frazier Investment Counselling first reported a position in Gilead Sciences in Q3 2016 and held it in 16 quarters.
- Bedell Frazier Investment Counselling's Gilead Sciences position peaked at $8.5M in Q3 2018.
- 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Bedell Frazier Investment Counselling's 13F filing for Q3 2020, filed 5 Nov 2020.